Particle infectivity of HIV-1 full-length genome infectious molecular clones in a subtype C heterosexual transmission pair following high fidelity amplification and unbiased cloning

Virology

Volumn 468, Issue , 2014, Pages 454-461

  Deymier, Martin J ^a   Claiborne, Daniel T ^a   Ende, Zachary ^a   Ratner, Hannah K ^a   Kilembe, William ^b   Allen, Susan ^b,c   Hunter, Eric ^a,c  

^a EMORY UNIVERSITY   (United States)

^b RZHRG   (Zambia)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amplification; Cloning; Fitness; HIV 1; Infectious molecular clones; Quasispecies; RNA virus; Transmission

Indexed keywords

GAG PROTEIN; TAR PROTEIN; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

AMINO ACID DELETION; AMPLICON; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE AMPLIFICATION; GENETIC VARIABILITY; HIGH FIDELITY AMPLIFICATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 SUBTYPE C; LONG TERMINAL REPEAT; MALE; MOLECULAR CLONING; PHENOTYPE; PHYLOGENETIC TREE; PHYLOGENY; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; VIRION; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS TITRATION; VIRUS TRANSMISSION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; NUCLEIC ACID AMPLIFICATION; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

CLONING, MOLECULAR; GENETIC VARIATION; GENOME, VIRAL; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PHYLOGENY; RNA, VIRAL;

EID: 84907486073     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2014.08.018     Document Type: Article

References (32)

1. Arts E.J., Hazuda D.J. HIV-1 antiretroviral drug therapy. Cold Spring Harb. Perspect. Med. 2012, 2:a007161.
2. Baalwa J., Wang S., Parrish N.F., Decker J.M., Keele B.F., Learn G.H., et al. Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones. Virology 2012, 436:33-48.
3. Carlson J.M., Schaefer M., Monaco D.C., Batorsky R., Claiborne D.T., Prince J., et al. Selection bias at the heterosexual HIV-1 transmission bottleneck. Science 2014, 345:1254031.
4. Claiborne D.T., Prince J.L., Hunter E. A restriction enzyme based cloning method to assess the in vitro replication capacity of HIV-1 subtype C Gag-MJ4 chimeric viruses. J. Vis. Exp. 2014, 90:e51506.
5. Coffin J., Swanstrom R. HIV pathogenesis: dynamics and genetics of viral populations and infected cells. Cold Spring Harb. Perspect. Med. 2013, 3:a012526.
6. Derdeyn C.A., Decker J.M., Bibollet-Ruche F., Mokili J.L., Muldoon M., Denham S.A., et al. Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science 2004, 303:2019-2022.
7. Dunkle K.L., Stephenson R., Karita E., Chomba E., Kayitenkore K., Vwalika C., et al. New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data. Lancet 2008, 371:2183-2191.
8. Eriksson S., Graf E.H., Dahl V., Strain M.C., Yukl S.A., Lysenko E.S., et al. Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies. PLoS Pathog. 2013, 9:e1003174.
9. Fenton-May A.E., Dibben O., Emmerich T., Ding H., Pfafferott K., Aasa-Chapman M.M., et al. Relative resistance of HIV-1 founder viruses to control by interferon-alpha. Retrovirology 2013, 10:146.
10. Fraser C., Lythgoe K., Leventhal G.E., Shirreff G., Hollingsworth T.D., Alizon S., et al. Virulence and pathogenesis of HIV-1 infection: an evolutionary perspective. Science 2014, 343:1243727.
11. Hotard A.L., Shaikh F.Y., Lee S., Yan D., Teng M.N., Plemper R.K., et al. A stabilized respiratory syncytial virus reverse genetics system amenable to recombination-mediated mutagenesis. Virology 2012, 434:129-136.
12. Keele B.F., Giorgi E.E., Salazar-Gonzalez J.F., Decker J.M., Pham K.T., Salazar M.G., et al. Identification and characterisation of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl. Acad. Sci. USA 2008, 105:7552-7557.
13. Lazouskaya N.V., Palombo E.A., Poh C.-L., Barton P.A. Construction of an infectious cDNA clone of Enterovirus 71: insights into the factors ensuring experimental success. J. Virol. Methods 2014, 197:67-76.
14. Lohmann V., Bartenschlager R. On the history of hepatitis C virus cell culture systems. J. Med. Chem. 2014, 57:1627-1642.
15. Meyerhans A., Cheynier R., Albert J., Seth M., Kwok S., Sninsky J., et al. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell 1989, 58:901-910.
16. Ndung'u T. Molecular cloning and biological characterization of full-length HIV-1 subtype C from Botswana. Virology 2000, 278:390-399.
17. Ndung'u T., Renjifo B., Essex M. Construction and analysis of an infectious human immunodeficiency virus type 1 subtype C molecular clone. J. Virol. 2001, 75:4964-4972.
18. Ochsenbauer C., Edmonds T.G., Ding H., Keele B.F., Decker J., Salazar M.G., et al. Generation of Transmitted/Founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages. J. Virol. 2012, 86:2715-2728.
19. Ostrowski, M.A., Chun, T.W., Cheseboro, B., Stanley, S.K., Tremblay, M., 2006. Detection assays for HIV proteins. Curr. Protoc. Immunol. Unit 12 15 (Chapter 12).
20. Parrish N.F., Gao F., Li H., Giorgi E.E., Barbian H.J., Parrish E.H., et al. Phenotypic properties of transmitted founder HIV-1. Proc. Natl. Acad. Sci. USA 2013, 110:6626-6633.
21. Phillips R.E., Rowland-Jones S., Nixon D.F., Gotch F.M., Edwards J.P., Ogunlesi A.O., et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 1991, 354:453-459.
22. Prince J.L., Claiborne D.T., Carlson J.M., Schaefer M., Yu T., Lahki S., et al. Role of transmitted Gag CTL polymorphisms in defining replicative capacity and early HIV-1 pathogenesis. PLoS Pathog. 2012, 8:e1003041.
23. Richman D.D., Wrin T., Little S.J., Petropoulos C.J. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc. Natl. Acad. Sci. USA 2003, 100:4144-4149.
24. Rousseau C.M., Birditt B.A., McKay A.R., Stoddard J.N., Lee T.C., McLaughlin S., et al. Large-scale amplification, cloning and sequencing of near full-length HIV-1 subtype C genomes. J. Virol. Methods 2006, 136:118-125.
25. Salazar-Gonzalez J.F., Bailes E., Pham K.T., Salazar M.G., Guffey M.B., Keele B.F., et al. Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J. Virol. 2008, 82:3952-3970.
26. Salazar-Gonzalez J.F., Salazar M.G., Keele B.F., Learn G.H., Giorgi E.E., Li H., et al. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J. Exp. Med. 2009, 206:1273-1289.
27. Sanchez G., Xu X., Chermann J.C., Hirsch I. Accumulation of defective viral genomes in peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected individuals. J. Virol. 1997, 71:2233-2240.
28. Shaw G.M., Hunter E. HIV transmission. Cold Spring Harb. Perspect. Med. 2012, 2:a006965.
29. UNAIDS Global Report 2013 2013, 1-198.
30. Wolfs T.F., Zwart G., Bakker M., Goudsmit J. HIV-1 genomic RNA diversification following sexual and parenteral virus transmission. Virology 1992, 189:103-110.
31. Wolinsky S.M., Wike C.M., Korber B.T., Hutto C., Parks W.P., Rosenblum L.L., et al. Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 1992, 255:1134.
32. Yanagi M., Purcell R.H., Emerson S.U., Bukh J. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc. Natl. Acad. Sci. USA 1997, 94:8738-8743.